Artificial Sweetener Sucralose May Reduce Cancer Treatment Effectiveness
TL;DR
New research indicates that sucralose, a common artificial sweetener found in products like Splenda, may impair the effectiveness of cancer immunotherapy by disrupting gut bacteria and reducing arginine levels, but supplementation with arginine could potentially counteract these effects. The study emphasizes the importance of considering dietary factors in cancer treatment outcomes.
- Warning issued for common artificial sweetener that can interfere with cancer treatments Yahoo Home
- Why cancer patients may have to avoid popular sugar substitute The Independent
- Common artificial sweetener may interfere with cancer treatments New Scientist
- Sucralose artificial sweetener could make cancer treatment less effective Medical Xpress
- Health Rounds: Artificial sweetener consumption linked to less effective cancer treatment Reuters
Want the full story? Read the original reporting
Read on Yahoo Home